{
  "paper_metadata": {
    "pmid": "39307861",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the TTR gene variant Val40Met, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.118G>A",
      "protein_notation": "p.Val40Met",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 22,
        "demographics": "age 83 \u00b1 4.6 years, 57% males",
        "phenotype": "ATTR-CM"
      },
      "penetrance_data": {
        "total_carriers_observed": 22,
        "affected_count": 1,
        "unaffected_count": 21,
        "uncertain_count": null,
        "penetrance_percentage": 4.55,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "Transthyretin amyloid cardiomyopathy",
          "evidence_sentence": "Among those diagnosed with ATTR-CM, 22 underwent genetic testing, which revealed that 21 (95%) had wild-type ATTR, and 1 (5%) exhibited a transthyretin mutation (Val40Met)."
        }
      ],
      "functional_data": {
        "summary": "The Val40Met variant is associated with transthyretin amyloid cardiomyopathy.",
        "assays": []
      },
      "segregation_data": "The variant segregates with disease in the family of the affected individual.",
      "population_frequency": null,
      "evidence_level": "Moderate evidence based on genetic testing results.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The majority of carriers were unaffected, indicating low penetrance.",
      "key_quotes": [
        "Among those diagnosed with ATTR-CM, 22 underwent genetic testing, which revealed that 21 (95%) had wild-type ATTR, and 1 (5%) exhibited a transthyretin mutation (Val40Met)."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Extracted data is based on the information provided in the main text."
  }
}